Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 225

Results For "ASH"

2935 News Found

ANI Pharmaceuticals consolidates operation post Novitium acquisition
News | June 06, 2022

ANI Pharmaceuticals consolidates operation post Novitium acquisition

Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023


APhA appoints Ilisa Bernstein Interim CEO
People | June 06, 2022

APhA appoints Ilisa Bernstein Interim CEO

Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA


Apollo Speciality Hospitals, Vanagaram organises vertigo awareness bicycle rally
Healthcare | June 06, 2022

Apollo Speciality Hospitals, Vanagaram organises vertigo awareness bicycle rally

The rally attracted around 250 riders, including professionals and amateurs.


Thyrocare opens regional processing lab in Ahmedabad
News | June 06, 2022

Thyrocare opens regional processing lab in Ahmedabad

New Regional Processing Lab will serve Ahmedabad and the state of Gujarat


Phygital model of med-tech seems to be quite Promising: opines Expert
Healthcare | June 04, 2022

Phygital model of med-tech seems to be quite Promising: opines Expert

To address the preventive & primary healthcare delivery gaps in India


Indian pharma market to grow at a CAGR of 12.3% to US$130 bn
News | June 04, 2022

Indian pharma market to grow at a CAGR of 12.3% to US$130 bn

PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030


Sanofi India appoints Preeti Futnani as GM, Vaccines
People | June 03, 2022

Sanofi India appoints Preeti Futnani as GM, Vaccines

Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.


GXO Logistics opens new warehouse for pharmaceutical sector
Supply Chain | June 03, 2022

GXO Logistics opens new warehouse for pharmaceutical sector

Facility features LED lighting, solar panels, automation and innovative temperature-controlled systems to maximize efficiency and minimize environmental impact


GSK to acquire clinical-stage biopharmaceutical company Affinivax for US$ 3.3 billion
News | June 03, 2022

GSK to acquire clinical-stage biopharmaceutical company Affinivax for US$ 3.3 billion

GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones


GSK to form consumer healthcare business ‘Haleon’
News | June 03, 2022

GSK to form consumer healthcare business ‘Haleon’

The proposed demerger is the most significant corporate change for GSK in the last 20 years